Morgan Stanley’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $906K | Sell |
|
|||||
|
2022
Q3 | $1.73M | Sell |
|
|||||
|
2022
Q2 | $5.97M | Sell |
|
|||||
|
2022
Q1 | $7.64M | Buy |
|
|||||
|
2021
Q4 | $4.25M | Buy |
|
|||||
|
2021
Q3 | $6.57M | Sell |
|
|||||
|
2021
Q2 | $8.85M | Buy |
|
|||||
|
2021
Q1 | $6.67M | Sell |
|
|||||
|
2020
Q4 | $13.3M | Sell |
|
|||||
|
2020
Q3 | $30.6M | Buy |
|
|||||
|
2020
Q2 | $5.61M | Buy |
|
|||||
|
2020
Q1 | $231K | Sell |
|
|||||
|
2019
Q4 | $892K | Buy |
|
|||||
|
2019
Q3 | $198K | Buy |
|
|||||
|
2019
Q2 | $123K | Sell |
|
|||||
|
2019
Q1 | $654K | Sell |
|
|||||
|
2018
Q4 | $5.26M | Buy |
|
|||||
|
2018
Q3 | $1.3M | Sell |
|
|||||
|
2018
Q2 | $3.3M | Buy |
|
|||||
|
2018
Q1 | $556K | Buy |
|
|||||
|
2017
Q4 | $48K | Buy |
|
|||||
|
2017
Q3 | $9K | Sell |
|
|||||
|
2017
Q2 | $87K | Buy |
|
|||||
|
2017
Q1 | $172K | Sell |
|
|||||
|
2016
Q4 | $528K | Buy |
|
|||||
|
2016
Q3 | $137K | Buy |
|
|||||
|
2016
Q2 | $64K | Sell |
|
|||||
|
2016
Q1 | $80K | Sell |
|
|||||
|
2015
Q4 | $258K | Buy |
|
|||||
|
2015
Q3 | $125K | Sell |
|
|||||
|
2015
Q2 | $2.62M | Sell |
|
|||||
|
2015
Q1 | $2.58M | Buy |
|
|||||
|
2014
Q4 | $1.18M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $10K | Buy |
|
|||||
|
2014
Q1 | $7K | Buy |
|